Pharmacological management of narcolepsy with and without cataplexy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2017-05-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14656566.2017.1323877PMID 28443381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.

  2017cited by this paper
• Steroid therapy ameliorated cataplexy in three children with recent-onset of narcolepsy.

  2017cited by this paper
• Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy

  2017cited by this paper
• Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.

  2016cited by this paper
• CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice

  2016cited by this paper
• Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.

  2016cited by this paper
• Transient Impact of Rituximab in H1N1 Vaccination–associated Narcolepsy With Severe Psychiatric Symptoms

  2016cited by this paper
• Modafinil Activates Phasic Dopamine Signaling in Dorsal and Ventral Striata

  2016cited by this paper
• Quality Measures for the Care of Patients with Narcolepsy

  2015cited by this paper
• Incidence of Narcolepsy in Germany.

  2015cited by this paper
• Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy.

  2015cited by this paper
• Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists.

  2015cited by this paper
• Narcolepsy.

  2015cited by this paper
• Effects of Hypocretin/Orexin Cell Transplantation on Narcoleptic-Like Sleep Behavior in Rats

  2014cited by this paper
• Effects of Hypocretin/Orexin Cell Transplantation on Narcoleptic-Like Sleep Behavior in Rats

  2014cited by this paper
• The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.

  2013cited by this paper
• Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.

  2013cited by this paper
• Nocturnal Temazepam in the Treatment of Narcolepsy

  2013cited by this paper
• Effects of Oral L-Carnitine Administration in Narcolepsy Patients: A Randomized, Double-Blind, Cross-Over and Placebo-Controlled Trial

  2013cited by this paper
• Sodium Oxybate for Narcolepsy with Cataplexy: Systematic Review and Meta-Analysis

  2012cited by this paper
• A remarkable effect of alemtuzumab in a patient suffering from narcolepsy with cataplexy

  2012cited by this paper
• Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.

  2012cited by this paper
• Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners.

  2012cited by this paper
• Sodium Oxybate for Narcolepsy with Cataplexy: Systematic Review and Meta-Analysis

  2012cited by this paper
• Sodium Oxybate in Narcolepsy with Cataplexy: Zurich Sleep Center Experience

  2011cited by this paper
• Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.

  2011cited by this paper
• Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis.

  2010cited by this paper
• Rapid occurrence of depression following addition of sodium oxybate to modafinil.

  2010cited by this paper
• The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.

  2010cited by this paper
• A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing.

  2010cited by this paper
• Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives

  2009cited by this paper
• Weight loss in narcolepsy patients treated with sodium oxybate.

  2009cited by this paper
• Successful Treatment of REM Sleep Behavior Disorder With Sodium Oxybate

  2009cited by this paper
• Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.

  2009cited by this paper
• An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.

  2008cited by this paper
• Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy

  2008cited by this paper
• No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy

  2008cited by this paper
• Restless legs syndrome in narcolepsy: a side effect of sodium oxybate?

  2007cited by this paper
• Treatment of narcolepsy and other hypersomnias of central origin.

  2007cited by this paper
• EFNS guidelines on management of narcolepsy

  2006cited by this paper
• The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy*

  2006cited by this paper
• Sodium oxybate improves excessive daytime sleepiness in narcolepsy.

  2006cited by this paper
• Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil.

  2005cited by this paper
• Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.

  2004cited by this paper
• Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset

  2004cited by this paper
• A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.

  2004cited by this paper
• The clinical spectrum of narcolepsy with cataplexy: a reappraisal

  2004cited by this paper
• Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects

  2004cited by this paper
• A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.

  2003cited by this paper
• Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.

  2003cited by this paper
• A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy

  2003cited by this paper
• Prevalence of narcolepsy symptomatology and diagnosis in the European general population

  2002cited by this paper
• A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.

  2002cited by this paper
• Increased production of evoked and spontaneous K-complexes following a night of fragmented sleep.

  2002cited by this paper
• Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study.

  2001cited by this paper
• Age at onset of narcolepsy in two large populations of patients in France and Quebec

  2001cited by this paper
• The use of citalopram in resistant cataplexy.

  2000cited by this paper
• Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy

  2000cited by this paper
• Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation.

  2000cited by this paper
• A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy.

  2000cited by this paper
• Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy

  2000cited by this paper
• Health-related quality of life effects of modafinil for treatment of narcolepsy.

  1999cited by this paper
• Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM‐sleep‐behavior disorder

  1999cited by this paper
• Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

  1997cited by this paper
• Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study.

  1995cited by this paper
• Treatment in the narcoleptic syndrome: self assessment of the action of dexamphetamine and clomipramine

  1995cited by this paper
• Modafinil: a double-blind multicentric study.

  1994cited by this paper
• Fluoxetine suppresses human cataplexy

  1994cited by this paper
• Treatment of narcolepsy with methamphetamine.

  1993cited by this paper
• Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.

  1993cited by this paper
• Effects of bromocriptine on periodic limb movements in human narcolepsy

  1993cited by this paper
• The treatment of excessive somnolence with stimulant drugs.

  1993cited by this paper
• Short-term triazolam use improves nocturnal sleep of narcoleptics.

  1992cited by this paper
• Mazindol in long-term treatment of narcolepsy.

  1991cited by this paper
• Nocturnal gamma-hydroxybutyrate. Effect on periodic leg movements and sleep organization of narcoleptic patients.

  1989cited by this paper
• Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.

  1989cited by this paper
• The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy.

  1989cited by this paper
• Fluoxetine in the treatment of cataplexy.

  1986cited by this paper
• Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline.

  1986cited by this paper
• Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.

  1986cited by this paper
• Amphetamine, mazindol, and fencamfamin in narcolepsy.

  1985cited by this paper
• Fluvoxamine and clomipramine in the treatment of cataplexy.

  1980cited by this paper
• The Treatment of Narcolepsy-Cataplexy with Nocturnal Gamma-Hydroxybutyrate

  1979cited by this paper
• EVALUATION of SHORT‐TERM and LONG‐TERM TREATMENT of the NARCOLEPSY SYNDROME WITH CLOMIPRAMINE HYDROCHLORIDE

  1976cited by this paper
• Treatment of cataplexy with clomipramine.

  1975cited by this paper
• Treatment of Cataplexy with Clomipramine.

  1975cited by this paper
• Pharmacotherapy in narcolepsy.

  1960cited by this paper
• Treatment of narcolepsy with Ritalin

  1959cited by this paper

• Orexin Restoration in Narcolepsy: Breakthroughs in Cellular Therapy

  2025cites this paper
• First Episode Psychosis in a Teen with Narcolepsy and Cataplexy.

  2025cites this paper
• Sleep and Long COVID—A Review and Exploration of Sleep Disturbances in Post Acute Sequelae of SARS-COV-2 (PASC) and Therapeutic Possibilities

  2024cites this paper
• [Characteristics of narcolepsy in childhood].

  2024cites this paper
• Armodafinil as Monotherapy in Treating Narcolepsy with Cataplexy

  2024cites this paper
• Circadian rhythm of daytime sleepiness in pediatric narcolepsy: A pilot study

  2023cites this paper
• Immortal orexin cell transplants restore motor-arousal synchrony during cataplexy.

  2023cites this paper
• Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals

  2022cites this paper
• Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort

  2022cites this paper
• Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation

  2022cites this paper
• Sleep in Schizophrenia

  2022cites this paper
• Prevalence, incidence, and health care utilization of patients with narcolepsy: a population-representative study

  2022cites this paper
• European guideline and expert statements on the management of narcolepsy in adults and children

  2021cites this paper
• Pitolisant for the treatment of cataplexy in adults with narcolepsy

  2021cites this paper
• Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know

  2021cites this paper
• Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials

  2021cites this paper
• Differenzialdiagnostik und Therapie von Hypersomnolenz-Erkrankungen

  2021cites this paper
• Epidemiology, Diagnostics, and Treatment of Narcolepsy in Germany: The DORMIO Study

  2021influential citation
• Neural circuitry underlying REM sleep: A review of the literature and current concepts.

  2021cites this paper
• European guideline and expert statements on the management of narcolepsy in adults and children

  2021cites this paper
• The NAergic locus coeruleus-ventrolateral preoptic area neural circuit mediates rapid arousal from sleep.

  2021cites this paper
• Chronic modafinil administration to preadolescent rats impairs social play behavior and dopaminergic system.

  2020cites this paper
• Pitolisant: A Review in Narcolepsy with or without Cataplexy

  2020cites this paper
• Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan

  2020cites this paper
• Attention-Deficit/Hyperactivity Disorder Patients May Have Undiagnosed Narcolepsy

  2020cites this paper
• Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy

  2020cites this paper
• Evaluating pitolisant as a narcolepsy treatment option

  2020cites this paper
• Narcolepsy, How do We Manage it?

  2020influential citation
• Narkolepsie im Erwachsenenalter: Definition, Ätiologie und Behandlung

  2020influential citation
• Erratum zu: Narkolepsie

  2020cites this paper
• Hypersomnie

  2020cites this paper
• NSS_A_218402 241..252

  2019cites this paper
• Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort

  2019cites this paper
• Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects

  2019cites this paper
• Multiple Sclerosis

  2019cites this paper
• The Risk of Hospitalization for Motor Vehicle Accident Injury in Narcolepsy and the Benefits of Stimulant Use: A Nationwide Cohort Study in Taiwan

  2019cites this paper
• Medical Complications After Moderate to Severe Traumatic Brain Injury

  2019cites this paper
• Health-Related Quality of Life in Patients With Narcolepsy: A Review of the Literature

  2019cites this paper
• Management of Excessive Daytime Sleepiness in Narcolepsy With Baclofen.

  2019cites this paper
• Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

  2019cites this paper
• CURRENT DEVELOPMENTS REGARDING GHB AND GBL INCIDENTS, TREATMENT AND DETECTION: A QUALITATIVE REVIEW

  2019cites this paper
• Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort.

  2019cites this paper
• Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy

  2019cites this paper
• Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.

  2019cites this paper
• Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study

  2019cites this paper
• Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment

  2019cites this paper
• Narcolepsy treatment: pharmacological and behavioral strategies in adults and children

  2019influential citation
• Multiple treatment comparison in narcolepsy: a network meta-analysis

  2018cites this paper
• Two Cases of Narcoleptic patients with sleep paralysis as a Chief Complaint

  2018cites this paper
• Review of Performance-enhancing Substances in the Military: Stimulants and Sedative-hypnotics

  2018cites this paper
• Important decisions in choosing the pharmacotherapy for narcoleptics

  2018cites this paper
• Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy

  2018cites this paper
• Narkolepsie im Erwachsenenalter: De fi nition, Ätiologie und Behandlung Narcolepsy in adults: De fi nition, etiology and treatment

  year unknowncites this paper